Treatment of chronic erythema nodosum with infliximab

被引：32

作者：

Clayton, T. H. ^{[1
]}

Walker, B. P. ^{[1
]}

Stables, G. I. ^{[1
]}

机构：

[1] Gen Infirm, Dept Dermatol, Leeds LS1 3EX, W Yorkshire, England

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2006年 / 31卷 / 06期

关键词：

D O I：

10.1111/j.1365-2230.2006.02221.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：823 / 824

页数：3

共 6 条

[1] The effect of infliximab on extraintestinal manifestations of Crohn's disease [J].

Kaufman, I ;

Caspi, D ;

Yeshurun, D ;

Dotan, I ;

Yaron, M ;

Elkayam, O .

RHEUMATOLOGY INTERNATIONAL, 2005, 25 (06) :406-410

[2]

Kugathasan S, 2000, AM J GASTROENTEROL, V95, P3189

[3] Tumour necrosis factor-α promoter polymorphism in erythema nodosum [J].

Labunski, S ;

Posern, G ;

Ludwig, S ;

Kundt, G ;

Bröcker, EB ;

Kunz, M .

ACTA DERMATO-VENEREOLOGICA, 2001, 81 (01) :18-21

[4]

Llorente L, 1997, EUR CYTOKINE NETW, V8, P67

[5]

Rahier JF, 2005, ACTA GASTRO-ENT BELG, V68, P376

[6] Failure of infliximab treatment and occurrence of erythema nodosum during therapy in two patients with Behcet's disease [J].

Yücel, AE ;

Kart-Köseoglu, H ;

Akova, YA ;

Demirhan, B ;

Boyacioglu, S .

RHEUMATOLOGY, 2004, 43 (03) :394-396

← 1 →